ELYVOPE

WIPO WIPO 2022

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark ELYVOPE was filed as Word mark on 02/21/2022 at the World Intellectual Property Organization.

Trademark Details Last update: December 19, 2022

Trademark form Word mark
File reference 1675281
Countries European Community
Base trademark US No. 90906331, August 27, 2021
Application date February 21, 2022
Expiration date February 21, 2032

Trademark owner

12830 El Camino Real, Suite 400
San Diego CA 92130
US

Trademark representatives

Sterne, Kessler, Goldstein & Fox P.L.L.C., 1100 New York Avenue, NW US

goods and services

05 Pharmaceuticals for use in the prevention and treatment of neurologic, genetic, psychologic, and psychiatric diseases and disorders
35 Promoting awareness of patient support offerings for neurologic, genetic, psychologic, and psychiatric diseases and disorders (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations); medical referrals
42 Scientific and industrial biotechnological and biomedical research; chemical, biochemical and molecular biological analyses; medical testing, namely, in vitro and in vivo preclinical testing of potential drugs (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations); consultation related thereto; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
44 Medical consulting with respect to neurologic, genetic, psychologic, and psychiatric diseases and disorders, including Rett syndrome and its identification and treatment; providing online information for health care providers, caregivers, and patients in the field of neurologic, genetic, psychologic, and psychiatric diseases and disorders; medical informational support services, namely, providing information about the benefits of diagnostic tools, medical information regarding disease diagnosis, identification, treatment, and management, and healthcare-related information to patients, caregivers, and healthcare professionals all related to neurologic, genetic, psychologic, and psychiatric diseases and disorders

Trademark history

Date Document number Area Entry
December 15, 2022 2022/50 Gaz EM Rejection
February 21, 2022 2022/28 Gaz US Registration

ID: 141675281